» Articles » PMID: 31000966

Gene-Environment-Time Interactions in Neurodegenerative Diseases: Hypotheses and Research Approaches

Overview
Journal Ann Neurosci
Publisher Sage Publications
Specialty Neurology
Date 2019 Apr 20
PMID 31000966
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Amyotrophic lateral sclerosis (ALS), Alzheimer's, and Parkinson's diseases are age-related neurodegenerative diseases. ALS is not a single entity but a syndrome with many different causes. In all 3 diseases, gene mutations account for only 10-15% of cases. Many environmental and lifestyle factors have been implicated as risk factors for ALS, though none have been proven to cause the disease. It is generally believed that ALS results from interactions between environmental risk factors and genetic predisposing factors. The advent of next-generation sequencing and recent advances in research into environmental risk factors offer the opportunity to investigate these interactions.

Summary: We propose a hypothesis to explain the syndrome of ALS based on the interaction of many individual environmental risk factors with many individual genetic predisposing factors. We hypothesize that there are many such combinations of individual, specific, genetic, and environmental factors, and that each combination can lead to the development of the syndrome of ALS. We also propose a hypothesis that explains the overlap between the age-related neurodegenerations and their genetic underpinnings. Age and duration of exposure are crucial factors in these age-related neurodegenerative diseases, and we consider how these may relate to gene-environment interactions.

Key Messages: To date, genetic studies and environmental studies have investigated the causes of ALS separately. We argue that this univariate approach will not lead to discoveries of important gene-environment interactions. We propose new research approaches to investigating gene-environment interactions based on these hypotheses.

Citing Articles

Exposure to Metals, Pesticides, and Air Pollutants: Focus on Resulting DNA Methylation Changes in Neurodegenerative Diseases.

Stoccoro A, Coppede F Biomolecules. 2024; 14(11).

PMID: 39595543 PMC: 11591912. DOI: 10.3390/biom14111366.


Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: A new perspective.

Alrouji M, Al-Kuraishy H, Al-Gareeb A, Alshammari M, Alexiou A, Papadakis M Neuropsychopharmacol Rep. 2024; 44(3):639-649.

PMID: 39075837 PMC: 11544450. DOI: 10.1002/npr2.12445.


Genetics of Hypertension: From Monogenic Analysis to GETomics.

Zappa M, Golino M, Verdecchia P, Angeli F J Cardiovasc Dev Dis. 2024; 11(5).

PMID: 38786976 PMC: 11121881. DOI: 10.3390/jcdd11050154.


Raw Water and ALS: A Unifying Hypothesis for the Environmental Agents Involved in ALS.

Stipa G, Ancidoni A, Vanacore N, Bellomo G Ann Neurosci. 2023; 30(2):124-132.

PMID: 37706096 PMC: 10496797. DOI: 10.1177/09727531221120358.


Pathomechanistic Networks of Motor System Injury in Amyotrophic Lateral Sclerosis.

Dey B, Kumar A, Patel A Curr Neuropharmacol. 2023; 22(11):1778-1806.

PMID: 37622689 PMC: 11284732. DOI: 10.2174/1570159X21666230824091601.


References
1.
Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A . Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 2000; 54(11):2072-7. DOI: 10.1212/wnl.54.11.2072. View

2.
Murch S, Cox P, Banack S . A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc Natl Acad Sci U S A. 2004; 101(33):12228-31. PMC: 514403. DOI: 10.1073/pnas.0404926101. View

3.
Murch S, Cox P, Banack S, Steele J, Sacks O . Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol Scand. 2004; 110(4):267-9. DOI: 10.1111/j.1600-0404.2004.00320.x. View

4.
Wild C . Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005; 14(8):1847-50. DOI: 10.1158/1055-9965.EPI-05-0456. View

5.
Driver J, Logroscino G, Gaziano J, Kurth T . Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology. 2009; 72(5):432-8. PMC: 2676726. DOI: 10.1212/01.wnl.0000341769.50075.bb. View